Step 2 CK · Neurology

Prion Disease & Rapidly Progressive Dementia

Name: Prion Disease & Rapidly Progressive Dementia
Creator: Veli Bakalov, MD

Rule out the reversible first; then MRI, EEG, and RT-QuIC name the prion

Neurology·Cognitive & Movement Disorders·4 min read·9 high-yield points·Reviewed by Veli Bakalov, MD @HemeOncBuddy

Study materialsNo account needed

Card deckActive-recall cards · quick checks · quiz

High-yield

Rapidly progressive dementia (weeks to months) demands exclusion of treatable mimics first: autoimmune encephalitis, Hashimoto encephalopathy, neurosyphilis, HIV, PML, CNS vasculitis, Wernicke, B12, nonconvulsive status, CNS lymphoma.
Parallel work-up: metabolic panel, TSH with anti-TPO, B12, RPR, HIV, MRI with DWI, EEG, and CSF with antibody panels and RT-QuIC.
Sporadic CJD: about age 60, dementia over weeks with startle myoclonus, ataxia, and visual symptoms → akinetic mutism; most die within a year.
MRI DWI cortical ribboning plus caudate/putamen hyperintensity is the most sensitive noninvasive test; EEG shows ~1-Hz periodic sharp-wave complexes.
CSF RT-QuIC is the most specific test; 14-3-3 and tau only mark rapid neuronal death; a CSF pleocytosis argues against CJD.
Variant CJD: young adult, psychiatric onset, painful dysesthesias, pulvinar sign, no periodic EEG complexes; acquired from BSE beef or transfusion.
Iatrogenic CJD follows cadaveric dura or corneal grafts, cadaveric pituitary hormones, and contaminated neurosurgical instruments.
Genetic prion disease (PRNP, autosomal dominant): familial CJD, Gerstmann-Sträussler-Scheinker, fatal familial insomnia.
No treatment: palliate, notify public health, use standard precautions for routine care, and destroy or specially decontaminate exposed instruments.

Approach to rapidly progressive dementia

Definition. Rapidly progressive dementia (RPD) is decline to dementia over weeks to months, usually within 1–2 years, compared with the years-long course of Alzheimer disease. Prion disease is the prototype, but many causes are reversible and must be excluded before an untreatable diagnosis is accepted. A handy checklist is VITAMINS: vascular, infectious, toxic-metabolic, autoimmune, metastases/neoplasm, iatrogenic (drugs), neurodegenerative, and seizures.

Treatable causes that mimic prion disease

Category	Examples	Clue or test
Autoimmune	Autoimmune or paraneoplastic encephalitis (anti-LGI1: faciobrachial dystonic seizures, hyponatremia); Hashimoto encephalopathy	Serum and CSF antibody panels; high anti-TPO, often euthyroid, steroid-responsive
Infectious	HIV-associated dementia; neurosyphilis (general paresis); PML	HIV test; treponemal test → CSF VDRL; JC virus in the immunosuppressed
Vascular	Primary CNS vasculitis	Multifocal infarcts, CSF pleocytosis, angiography or biopsy
Toxic-metabolic	Wernicke; B12 deficiency; hypothyroidism; hepatic or uremic encephalopathy; lithium or bismuth toxicity	Empiric thiamine, B12, TSH, ammonia, drug levels
Seizures	Nonconvulsive status epilepticus (fluctuating confusion, subtle twitching)	EEG
Neoplastic	Primary CNS or intravascular lymphoma; paraneoplastic syndromes	Contrast MRI, CSF cytology and flow, body CT ± PET

Work-up

Evaluate in parallel rather than one test at a time:

History and examTempo, myoclonus, exposures (grafts, hormones, residence), drugs, immune status
BloodElectrolytes, calcium, glucose, renal and liver tests, ammonia, TSH with anti-TPO, B12, RPR/treponemal test, HIV
MRI with DWI and contrastPrion pattern, encephalitis, infarcts, lymphoma
EEGNonconvulsive status; periodic sharp-wave complexes
Lumbar punctureCells, protein, VDRL, cytology and flow, autoimmune antibodies, RT-QuIC, 14-3-3, tau
Cancer screenCT chest, abdomen, and pelvis ± FDG-PET if a paraneoplastic process is possible

Treat what you find at once: thiamine for possible Wernicke, IV penicillin G for neurosyphilis, antiseizure drugs for nonconvulsive status, glucocorticoids for Hashimoto encephalopathy.

Sporadic Creutzfeldt-Jakob disease

Prion biology. Normal prion protein (PrPC, α-helical; PRNP on chromosome 20) is converted into a β-sheet-rich, protease-resistant isoform (PrPSc) that templates further misfolding, a transmissible agent with no nucleic acid. The brain shows spongiform vacuolation, neuronal loss, and gliosis without inflammation, which is why the CSF stays bland. Sporadic CJD is about 85% of prion disease, at about 1–2 per million people per year.

Clinical picture. Patients are typically about 60 (55–75). A vague prodrome of fatigue, insomnia, or anxiety gives way to dementia progressing over weeks, startle-sensitive myoclonus, cerebellar ataxia, visual disturbance (distortions, cortical blindness), and pyramidal or extrapyramidal signs, ending in akinetic mutism. Median survival is about 4–6 months, and most patients die within a year.

Diagnostic tests in sporadic CJD

Test	Finding	Comment
MRI DWI and FLAIR	Cortical ribboning; caudate/putamen hyperintensity; no enhancement	Most sensitive noninvasive test; DWI often more striking than FLAIR
EEG	Generalized periodic sharp-wave complexes, ~1 per second	Mid-to-late finding; also excludes nonconvulsive status
CSF RT-QuIC	Prion seeding activity	About 90% sensitive, nearly 100% specific
CSF 14-3-3, total tau	Elevated	Nonspecific: rapid neuronal death from stroke, seizures, or encephalitis also raises them
Routine CSF	Normal cell count	Pleocytosis suggests another diagnosis
Brain biopsy or autopsy	Spongiform change, PrPSc	Definitive; biopsy rarely needed

Restricted diffusion that follows the cortical ribbon across vascular territories and persists for weeks points to prion disease rather than stroke.

Variant, iatrogenic, and genetic prion disease

Variant CJD. Acquired from beef contaminated with bovine spongiform encephalopathy ("mad cow" disease), mostly in the UK in the 1990s. Median onset is in the late 20s with depression, anxiety, or withdrawal, followed by persistent painful dysesthesias, ataxia, involuntary movements, and dementia over about 1–1.5 years. MRI shows the pulvinar sign (bilateral posterior thalamic hyperintensity), whereas Wernicke encephalopathy favors the medial thalami and mammillary bodies. The EEG usually lacks periodic complexes. Because lymphoid tissue is involved, tonsil biopsy can show PrPSc, and blood transfusion has transmitted the disease.

Iatrogenic CJD. Cadaveric dura mater and corneal grafts, cadaveric pituitary growth hormone or gonadotropins, and contaminated neurosurgical instruments or depth electrodes have transmitted prions, with incubation of years to decades. Recombinant hormones carry no prion risk.

Genetic prion disease. About 10–15% of cases stem from autosomal dominant PRNP mutations:

Familial CJD (E200K most common): resembles sporadic CJD.
Gerstmann-Sträussler-Scheinker: slowly progressive ataxia, then dementia over years.
Fatal familial insomnia (D178N): intractable insomnia, dysautonomia, and thalamic degeneration.

A family history may be missing, so PRNP testing with genetic counseling is offered when prion disease is suspected. Kuru, spread by ritual funerary cannibalism among the Fore people of Papua New Guinea, was the first human prion disease shown to be transmissible.

Management and infection control

Care. No therapy alters the course. Treat myoclonus with clonazepam, levetiracetam, or valproate, and address feeding, goals of care, and hospice early. CJD is reportable: notify public health and consider autopsy confirmation.

Precautions. Prions do not spread by casual contact or through the air, so routine care uses standard precautions and no isolation room. The infectious risk lies in brain, spinal cord, pituitary, and posterior-eye tissue. Patients with prion disease are excluded from blood, tissue, and organ donation.

Prions resist formalin, standard autoclaving, alcohol, and radiation: instruments used on suspected cases are discarded or decontaminated with sodium hydroxide or concentrated bleach plus extended 134 °C autoclaving.